Inês Martins, PhD, managing science editor —

NurOwn, a cell-based therapy that protects and helps repair nerve cells, also may be able to curb the damaging brain inflammation that contributes to the progression of amyotrophic lateral sclerosis (ALS), recent findings suggest. Researchers believe this newly-found potential may extend the…

ProMIS Neurosciences announced its program for amyotrophic lateral sclerosis (ALS) is advancing, and scientists were able to generate a specific type of antibody against toxic TDP-43 protein clumps — a hallmark of this disease — that continuously damage nerve cells. These antibodies, called intrabodies because they…

Agriculture and other areas that expose people to pesticides, paint solvents, electromagnetic fields, and heavy metals may increase their odds of developing amyotrophic lateral sclerosis (ALS), a population-based study from Italy shows. But larger studies are needed to confirm these findings, its researchers wrote, as only some risk factors…

Computer scientists at Stony Brook University have been awarded $200,000 by the ALS Association to continue the development of a mobile app that helps people with amyotrophic lateral sclerosis (ALS), and others whose mobility has been impaired, to regain some of their independence. According to a…

Identifying blood biomarkers that reflect the metabolic changes occurring in people with amyotrophic lateral sclerosis (ALS) may be among the most promising approaches to diagnosing patients in the early stages of disease, sometimes years before motor symptoms appear, a review study suggests. The study, “Importance of the…

A branch of the European Medicines Agency (EMA) has recommended that Amylyx‘s investigational oral compound AMX0035 be designated an orphan medicine to treat people with amyotrophic lateral sclerosis (ALS). Orphan designation is given to medicines in Europe with the potential to be safe…

Reducing the excess firing of motor neurons in an animal model of amyotrophic lateral sclerosis (ALS) prevents the death of nerve cells and significantly delays the onset of motor symptoms, a recent study has found. Because the scientific approach made use of two techniques that have been studied extensively…

A team at the Rowan University School of Osteopathic Medicine has received a $1.6 million grant to study the role of the SOD1 protein — whose gene is often mutated in amyotrophic lateral sclerosis (ALS) — in the communication between the gut and the brain. The National Institutes…

A weak link only between a person’s current smoking study and greater risk of amyotrophic lateral sclerosis (ALS) was seen by scientists in a U.K. study, with no evidence that lifetime smoking exposure affects such risk. The researchers believe that this weak association is likely a “false-positive,” and there…

A  way of examining multiple genes or the entire human genome at the same time, called next-generation sequencing (NGS), is a promising tool for diagnosing amyotrophic lateral sclerosis (ALS) in routine clinical practice, a review study suggests. This method’s approach is faster and less expensive than the standard…